<?xml version="1.0"?>

<document>
	<title>Classes of skin fibroblast metachromasia in cystic fibrosis
   correlated with lung function tests.</title>

	<author>Lykkegaard-E.</author>
	<author>Pedersen-J-T.</author>

	<source>Dan-Med-Bull. 1975 Jul. 22(5). P 175-7.</source>

	<abstract>Lung function tests were conducted in 35 patients with cystic
   fibrosis and correlated to class of skin fibroblast metachromasia.
   Seven patients belonged to class I (vesticular metachromasia), 16 to
   class II (generalized metachromasia), and 12 to class III (no
   metachromasia).  Class I patients had significantly lower vital
   capacity (VC) than class II patients.  As regards the other lung
   function tests, no general trends were found in class I patients
   compared with the other two classes.  For class III patients the lung
   function tests reflected more serious lung changes than those of
   class II patients; statistically significant differences were found
   as regards residual volume/total lung capacity, one-second forced
   expiratory volume (FEV1), and FEV1/VC.  The differences were not due
   to varying intensity of treatment.  The results are in accordance
   with the findings in a previous study of the clinical and
   radiological lung symptoms and serum protein values in CF when
   correlated to metachromatic classes.</abstract>

	<majorsubject>CYSTIC-FIBROSIS: pp</majorsubject>
	<majorsubject>LUNG: pp</majorsubject>

	<minorsubject>ADOLESCENCE</minorsubject>
	<minorsubject>ADULT</minorsubject>
	<minorsubject>BIOPSY</minorsubject>
	<minorsubject>CELLS-CULTURED</minorsubject>
	<minorsubject>CHILD</minorsubject>
	<minorsubject>CYSTIC-FIBROSIS: pa</minorsubject>
	<minorsubject>FEMALE</minorsubject>
	<minorsubject>FIBROBLASTS</minorsubject>
	<minorsubject>HUMAN</minorsubject>
	<minorsubject>MALE</minorsubject>
	<minorsubject>RESPIRATORY-FUNCTION-TESTS</minorsubject>
	<minorsubject>SKIN: pa</minorsubject>
	<minorsubject>STAINS-AND-STAINING</minorsubject>

	<reference>001   DANES BS              IN: LAWSON D PROC 5TH INT CF          67 969</reference>
	<reference>002   DANES BS              LANCET                           1  1061 968</reference>
	<reference>003   DANES BS              J EXP MED                      129   775 969</reference>
	<reference>004   DANES BS              AM J HUM GENET                  23   297 971</reference>
	<reference>005   HOYBYE G              UGESKR LAEGER                  132  2007 970</reference>
	<reference>006   LYKKEGAARD E          DAN MED BULL                    22   169 975</reference>
	<reference>007   THUESEN-PEDERSEN J    DAN MED BULL                    21    12 974</reference>
	<reference>008   POGUE RE              MINN MED                        52  1551 969</reference>
	<reference>009   POLGAR G              PULMONARY FUNCTION TESTING IN            971</reference>

	<citation>1   LYKKEGAARD E          DAN MED BULL                    22   177 975</citation>
	<citation>2   LYKKEGAARD E          DAN MED BULL                    22   169 975</citation>
	<citation>3   WEEKE B               DAN MED BULL                    23   155 976</citation>
	<citation>4   DANES BS              CLIN GENET                      11    83 977</citation>
	<citation>5   DANES BS              CLIN GENET                      13   327 978</citation>
	<citation>6   JAKEL HP              BIOL ZENTRALBL                  98    55 979</citation>
	<citation>7   WINGE P               DAN MED BULL                    29   358 982</citation>
	<citation>8   BECK B                ACTA PAEDIATR SCAND SUPPL 301 1982   125 982</citation>

</document>
